Avoiding Adverse Drug Reactions with Pharmacogenomics
- 9 MIN READ
This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on precision health. Browse all Precision Health education
Adverse drug reactions are a significant cause of avoidable harm, and genetics is one factor that helps explain why they happen to some people and not others. Pharmacogenomics — PGx — studies how your genes affect the way you process medications. This article explains how PGx relates to adverse drug reactions and how it differs from the PlexusDx Precision Peptide Genetic Test.
How Genes Influence Adverse Drug Reactions
Most medications are broken down by liver enzymes, and the genes coding those enzymes vary. When someone is a poor metabolizer of a given pathway, a standard dose can build up and raise side-effect risk; a rapid metabolizer may clear a drug too quickly. These differences are part of why the same prescription can be well tolerated by one person and cause problems for another.
The Genes Pharmacogenomics Examines
CYP2C19 and CYP2D6 affect how quickly many common drugs are metabolized. VKORC1 affects sensitivity to certain blood thinners, TPMT influences tolerance of specific immunosuppressants, and DPYD affects the processing of certain chemotherapy agents. Pharmacogenomic testing, ordered and interpreted by a clinician, is built around variants like these.
What PGx Can and Cannot Do
A pharmacogenomic test can help a clinician anticipate adverse-reaction risk for the specific drugs it covers. It cannot cover every medication or replace clinical judgment. Never interpret a result on your own — organ function, other prescriptions, and your health history all shape what a result means.
How PGx Differs From the Precision Peptide Genetic Test
This distinction matters, and PlexusDx states it plainly: PlexusDx does not sell or offer a pharmacogenomic (PGx) test. The PlexusDx Precision Peptide Genetic Test is not a pharmacogenomic test. It does not analyze drug-metabolizing enzymes and does not predict your response to any medication. Instead, it examines peptide-related biological pathways — spanning 14 pathways, 49 peptides, 150+ genetic insights — to offer pathway-level context about your baseline biology. If you want insight into how you metabolize a specific prescription, that is a separate pharmacogenomic conversation to have with your provider. Genetics is a guide, not a guarantee.
Using Genetic Information Responsibly
Whatever genetic testing you pursue, the principle is the same: never start, stop, or change a medication based on a genetic result alone. Bring any report to a qualified healthcare provider or pharmacist who can interpret it in the full context of your care, including your other prescriptions and health history. Used that way, genetic insight turns guesswork into a more informed conversation — genetics is a guide, not a directive.
Frequently Asked Questions
Can PGx testing prevent all adverse drug reactions?
No. PGx testing addresses only the genetic contribution to how you metabolize certain drugs, for the medications a given test covers. Many reactions have non-genetic causes. A clinician interprets PGx results alongside your full clinical picture.
Is the Precision Peptide Genetic Test a pharmacogenomic test?
No. The Precision Peptide Genetic Test is not a pharmacogenomic test and does not predict response to any medication. PlexusDx does not sell a PGx test. The Precision Peptide Genetic Test analyzes peptide-related biological pathways for pathway-level context about your biology. For insight into how you metabolize a specific drug, ask your provider about dedicated pharmacogenomic testing.
Can I change my medications based on a genetic test?
No. Never start, stop, or adjust any medication based on a genetic result alone. Genetic information is one input among many, including your diagnosis, other drugs, and organ function. Always review any report with a qualified healthcare provider or pharmacist before making medication decisions.
Curious about your own peptide-pathway genetics? The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — pathway-level context you can bring to your healthcare provider. It is educational insight into your biology, not a diagnosis, a prescription, or a pharmacogenomic test.
This article is part of the PlexusDx Education Hub. Browse all Precision Health education
PlexusDx does not sell or offer a pharmacogenomic (PGx) test. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not predict response to any specific medication and does not recommend, prescribe, or determine which peptides or drugs you should use. Consult a qualified healthcare provider before making any medication or peptide decision.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. PlexusDx does not offer a pharmacogenomic test. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
The Economics of Genetic Testing: Cost vs. Benefit Analysis
Personalized Nutrition Plans: The Role of NGx Testing in Weight Management